Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ProIX obtains development and marketing rights for novel PI-3K inhibitors

Aug. 24, 2004

A cyanoguanidine-based prodrug identified as a clinical candidate by Leo scientists

Aug. 24, 2004

Protox Therapeutics retains CTBR for preclinical testing of PSA-PA1

Aug. 23, 2004

Viventia Biotech and Acceptys enter option agreement for anticancer antibodies

Aug. 23, 2004

Taxotere approved for early-stage breast cancer

Aug. 23, 2004

New phase I/II study of CG-7870 plus Taxotere for prostate cancer

Aug. 23, 2004

New EGFR inhibitors identified by Ariad scientists

Aug. 23, 2004

Fast track status for temsirolimus for first-line treatment of advanced RCC

Aug. 19, 2004

MediGene acquires anticancer drugs and technology of Munich Biotech

Aug. 19, 2004

Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...